Development and validation of the Functional Assessment of Human Immunodeficiency Virus Infection (FAHI) quality of life instrument

Quality of Life Research

Volumn 5, Issue 4, 1996, Pages 450-463

  Cella, D F ^a   McCain, N L ^b   Peterman, A H ^a   Mo, F ^a   Wolen, D ^c  

^a RUSH UNIVERSITY MEDICAL CENTER   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c Department of Ambulatory and Community Health   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PSYCHOMETRY; QUALITY OF LIFE; QUESTIONNAIRE;

EID: 0029814433     PISSN: 09629343     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf00449920     Document Type: Article

References (41)

1. Winiarski MG. AIDS-related psychotherapy. New York: Pergamon Press, 1991.
2. Osmond DH. HIV disease progression from infection to CDC-defined AIDS: Incubation period, cofactors, and laboratory markers. In: Cohen PT, Sande MA, Volberding PA, eds. The AIDS Knowledge Base. Boston: Little, Brown, 1994a: 1.7.1-1.7.19.
3. Osmond DH. Trends in HIV disease survival time. In: Cohen PT, Sande MA, Volberding PA, eds. The AIDS Knowledge Base. Boston: Little, Brown, 1994a: 1.3.1-1.3.7.
4. Cohen PT, Volberding PA. Clinical spectrum of HIV disease. In: Cohen PT, Sande MA, Volberding PA, eds. The AIDS Knowledge Base. Boston: Little, Brown, 1994a: 4.1.1-4.1.15.
5. Cella DF. Quality of life: Concepts and definition. J Pain Symp Mgmt 1994b; 9: 186-192.
6. Wu AW, Rubin HR. Measuring health status and quality of life in HIV and AIDS. Psychol Health 1992; 6: 251-264.
7. Lee BL, Safrin S. Drug interactions and toxicities in patients with HIV disease. In: Cohen PT, Sande MA, Volberding PA, eds. The AIDS Knowledge Base. Boston: Little, Brown, 1994a: 4.6.1-4.6.18.
8. Perry S, Jacobsberg G, Fishman B, Weiler PH, Gold JWM, Frances A. Psychological responses to serological testing for HIV. AIDS 1990; 4: 145-152.
9. Schaffner B. Psychotherapy with HIV-infected persons. New Dir Mental Health 1990; 48: 5-20.
10. Pizzi M, Mukand J, Freed MM. HIV infection and occupational therapy. In: Mukand J, ed. Rehabilitation for Patients with HIV Disease. New York: McGraw-Hill, 1991: 283-326.
11. Hays RD, Shapiro MF. An overview of generic health-related quality of life measures for HIV research. Qual Life Res 1992; 1: 91-97.
12. Tsevat J. Methods for assessing health-related quality of life in HIV-infected patients. Psychol Health 1994; 9:19-30.
13. Kaplan RM, McCutchan JA, Navarro AM, Anderson JP. Quality adjusted survival analysis: A neglected application of the Quality of Well-being Scale. Psychol Health 1994; 9: 131-141.
14. Ragsdale D, Morrow JR. Quality of life as a function of HIV classification. Nursing Res 1990; 39: 355-359.
15. Wu AW, Rubin HR, Mathews WC, et al. A health status questionnaire using 30 items from the Medical Outcomes Study. Med Care 1991; 29: 786-798.
16. Lubeck DP, Fries JF. Changes in quality of life among persons with HIV infection. Qual Life Res 1992; 1: 359-366.
17. Lubeck DP, Fries JF. Changes in health status after one year for persons at-risk for and with HIV infection. Psychol Health 1994; 9: 79-92.
18. deBoer JB, Sprangers MAG, Aaronson NK, Lange JMA, van Dam FSAM. The feasibility, reliability and validity of the EORTC QLQ-C30 in assessing the quality of life of patients with asymptomatic HIV infection or AIDS (CDC IV). Psychol Health 1994; 9: 65-77.
19. Ganz PA, Schag CAC, Kahn B, Petersen L. Assessing the quality of life of HIV infected persons: Clinical and descriptive information from studies with the HOPES. Psychol Health 1994; 9: 93-110.
20. Ganz PA, Schag CAC, Kahn B, Petersen L, Hirji K. Describing the health-related quality of life impact of HIV infection: Findings from a study using the HIV Overview of Problems-Evaluation System (HOPES). Qual Life Res 1993; 2: 109-119.
21. Schag CAC, Ganz PA, Petersen L. Assessing the needs and quality of life of patients with HIV infection: Development of the HIV Overview of Problems-Evaluation System (HOPES). Qual Life Res 1992; 1: 397-413.
22. Cella DF. F.A.C.T. manual: Manual for the Functional Assessment of Cancer Therapy (FACT) scales and the Functional Assessment of HIV Infection (FAHI) scale. Chicago: Rush-Presbyterian-St. Luke's Medical Center, 1994a.
23. McCain NL, Cella DF. Correlates of stress in HIV disease. Western J Nur Res 1995; 17: 141-155.
24. Cella DF, McCain NL. Validation of a quality of life instrument for people with human immunodeficiency virus infection [Abstract]. Proceedings of the 16th Annual Meeting of the Society of Behavioral Medicine. Washington: Society of Behavioral Medicine, 1995.
25. Cella DF, Tulsky DS, Gray G, et al. The Functional Assessment of Cancer Therapy scale: Development and validation of the general measure. J Clin Oncot 1993; 11: 570-579.
26. Aaronson NK, Bullinger M, Ahmedzai S. A modular approach to quality-of-life assessment in cancer clinical trials. Rec Results Cancer Res 1988; 11: 231-249.
27. Cella DF, Tulsky DS. Measuring quality of life today: Methodological aspects. Oncol 1990; 4: 29-38.
28. Cella DF, Bonomi AE. Measuring quality of life: 1995 update. Oncol 1995; 9: 47-60.
29. Cella DF, Bonomi AE. The Functional Assessment of Cancer Therapy (FACT) and Functional Assessment of HIV Infection (FAHI) quality of life measurement system. In: Spilker B, ed. Quality of Life and Pharmacoeconomics in Clinical Trials (2nd ed). New York: Raven Press, 1995: 203-214.
30. McCain NL, Zeller JM, Cella DF, Urbanski PA, Novak RM. The influence of stress management training in HIV disease. Nursing Res In press.
31. Karnofsky DA, Abelmann WH, Graver LF, Burchenal JH. The use of the nitrogen mustards in the palliative treatment of carcinoma. Cancer 1948; 1: 634-656.
32. McCain NL, Gramling LF. Living with dying: Coping with HIV-disease. Issues in Mental Health Nursing 1992; 13: 271-284.
33. Cella DF, Jacobsen PB, Orav EJ, Holland JC, Silberfarb PM, Rafla S. A brief POMS measure of distress for cancer patients. J Chronic Dis 1987; 40: 939-942.
34. Horowitz M, Wilner N, Alvarez W. Impact of Event Scale: A measure of subjective stress. Psychosom Med 1979; 41: 209-218.
35. Mishel MH. The measurement of uncertainty in illness. Nurs Res 1981; 30: 258-263.
36. Mishel MH. Perceived uncertainty and stress in illness. Res Nurs Health 1984; 7: 163-171.
37. Centers for Disease Control (CEXI). 1993 revised classification system for HIV infection and expanded surveillance case definition for AIOS among adolescents and adults. Morbidity and Mortality Weekly Report 1992; 41 (No. RR-17).
38. Zubrod CG, Schneiderman M, Frei E III, et al. Appraisal of methods for the study of chemotherapy of cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chronic Dis 1960; 11: 7-33.
39. Nunnally JC. Psychometric Theory (2nd ed). New York: McGraw-Hill, 1978.
40. DeVellis RF. Scale Development: Theory and Applications. Newbury Park, CA: Sage, 1991.
41. Helmstadter GC. Principles of psychological measurement. New York: Appleton-Century-Crofts, 1964.